D. Thomas-Beaulieu

Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population.

O. Dereure, M. Richard, G. Jeudy, 2019, The Journal of investigative dermatology.

Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema.

D. Lipsker, A. Dupuy, M. Rybojad, 2020, Blood.

Psoriasis in the elderly: epidemiological and clinical aspects, and evaluation of patients with very late onset psoriasis

M. Lahfa, B. Labeille, A. Beauchet, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Successful treatment with ixekizumab of lower-limb linear psoriasis in a child.

E. Mahé, D. Thomas-Beaulieu, L. Mery-Bossard, 2022, Annales de dermatologie et de venereologie.

Real-World Effectiveness and Safety of Apremilast in Older Patients with Psoriasis

M. Romanelli, E. Cinotti, J. Perrot, 2020, Drugs & Aging.

Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real‐world clinical setting

H. Maillard, J. Perrot, A. Beauchet, 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis

M. Romanelli, E. Cinotti, J. Perrot, 2020, Acta dermato-venereologica.

Tattoo complications in treated and non‐treated psoriatic patients

J. Perrot, A. Beauchet, N. Kluger, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years

K. Ezzedine, A. Beauchet, E. Mahé, 2014, European Journal of Dermatology.